Intel Analysis: Attempt to Hold Above the Profile Following a False Trend Breakout

FXOpen

On 8 September, Northland Securities upgraded Intel to Outperform with a price target of $120, citing a shortage of server processors, progress in the company’s business turnaround and potential benefits from its involvement in the Terafab project with Tesla and SpaceX. On the same day, reports emerged that Intel was planning to raise processor prices by around 10% from October amid rising costs and limited supply across the supply chain. The combination of higher prices and a positive rating revision is helping to sustain investor interest in Intel shares against the backdrop of strong performance across the semiconductor sector.

Intel Technical Analysis

From 30 June to 29 July, a short-term trend formed on the INTC four-hour chart. Following a decline, the market corrected higher, with the rebound forming an ascending trendline. The price subsequently broke below this trendline, but the attempted breakout was not confirmed by the RSI + MAs indicator. As a result, the price reversed direction and quickly moved through the current market profile, breaking above its upper boundary at $100.00 and is now attempting to establish itself above this level.

It is worth noting that the red resistance level at $109.00 is relatively close to the current price, while the RSI + MAs indicator currently stands at 75, 56 and 51. The RSI has already entered overbought territory, while the moving averages have yet to leave the neutral zone, making the current breakout attempt look questionable. If the market produces another false breakout, a return into the market profile could bring several important levels into play, including the Point of Control (POC) at $92.00 and the lower boundary of the profile at $86.00. Below this level, and relatively close to it, lies the green support level around $82.00.

Key Takeaways

The RSI being in overbought territory while the moving averages remain in the neutral zone casts doubt on a potential breakout of the profile. The short distance to the red resistance level could also strengthen the current resistance zone. Investor reaction to the planned price increase in October could provide an additional factor influencing the stock’s price action.

Buy and sell stocks of the world's biggest publicly-listed companies with CFDs on FXOpen’s trading platform. Open your FXOpen account now or learn more about trading share CFDs with FXOpen.

This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.

Stay ahead of the market!

Subscribe now to our mailing list and receive the latest market news and insights delivered directly to your inbox.

forex

Share CFD Trading with FXOpen

Share CFD Trading with FXOpen

Experience ECN technology for deep liquidity and light-speed trade execution

  • Trade with tight spreads
  • Take advantage of low commissions
  • Choose from 4 trading platforms: MT4, MT5, TradingView, or TickTrader
Learn more

Latest articles

Forex Analysis

CAD/JPY: The Yen's Most Historic Move in 30 Years Meets a Fragile Support

Two central banks are heading in genuinely opposite directions this week, and the tension is unmistakable. The Bank of Canada held rates steady at 2.25% on September 2, with a mildly hawkish tilt as policymakers acknowledged a broadening economic

Forex Analysis

USD/JPY and USD/CAD Await Key Fed Decision

The US dollar is consolidating against the yen and Canadian dollar ahead of the key event of the week — the Federal Reserve meeting. The Fed is widely expected to raise its policy rate by 25 basis points to a range

Shares

UnitedHealth: Fundamentals Are Healing, Now the Chart Must Agree

UnitedHealth finds itself in a genuinely split narrative right now, trading near $388, down about 15.9% from its 52-week high, even as the fundamental picture keeps improving. Q2 earnings beat expectations, with revenue of $112.03 billion, and the

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 60% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.